Page last updated: 2024-09-02

tadalafil and Pelvic Pain

tadalafil has been researched along with Pelvic Pain in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's6 (54.55)24.3611
2020's5 (45.45)2.80

Authors

AuthorsStudies
Abdulmonem, M; Abo-Elenen, M; Aboufarha, MO; Elgamal, SA; Radwan, MH; Tawfik, AM1
Bai, Y; Dong, Z; Lao, Y; Wang, Y1
Amano, T1
Tanaka, T1
Asao, Y; Kurita, M; Oka, M; Yamaguchi, H; Yoshinaga, R1
Fujita, T; Funahashi, Y; Gotoh, M; Ishida, S; Kato, M; Matsukawa, Y; Naito, Y; Tochigi, K1
Deguchi, T; Fujihiro, S; Kikuchi, M; Masue, T; Miwa, K; Moriyama, Y; Nakai, C; Nishino, Y1
Kurita, M; Numakura, Y; Oka, M; Okamoto, K; Yamaguchi, H1
Kotera, T; Kurita, M; Oka, M; Okamoto, K; Yamaguchi, H2
Chatterjee, S; Russell, A; Seed, M1

Reviews

1 review(s) available for tadalafil and Pelvic Pain

ArticleYear
[Experimental rodent models of chronic prostatitis: effect of phosphodiesterase 5 inhibitor on chronic pelvic-pain-related behavior].
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2019, Volume: 154, Issue:5

    Topics: Animals; Chronic Pain; Disease Models, Animal; Humans; Male; Pelvic Pain; Phosphodiesterase 5 Inhibitors; Prostatitis; Rodentia; Tadalafil

2019

Trials

2 trial(s) available for tadalafil and Pelvic Pain

ArticleYear
Tadalafil monotherapy in management of chronic prostatitis/chronic pelvic pain syndrome: a randomized double-blind placebo controlled clinical trial.
    World journal of urology, 2022, Volume: 40, Issue:10

    Topics: Chronic Disease; Chronic Pain; Humans; Male; Middle Aged; Pelvic Pain; Phosphodiesterase 5 Inhibitors; Prostatitis; Tadalafil

2022
Comparison of cernitin pollen extract vs tadalafil therapy for refractory chronic prostatitis/chronic pelvic pain syndrome: A randomized, prospective study.
    Neurourology and urodynamics, 2020, Volume: 39, Issue:7

    Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Drug Resistance; Drug Therapy, Combination; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Pelvic Pain; Plant Extracts; Pollen; Prospective Studies; Prostatitis; Tadalafil; Treatment Outcome; Urodynamics

2020

Other Studies

8 other study(ies) available for tadalafil and Pelvic Pain

ArticleYear
Comment on "Tadalafil monotherapy in management of chronic prostatitis/chronic pelvic pain syndrome: a randomized double‑blind placebo controlled clinical trial".
    World journal of urology, 2022, Volume: 40, Issue:10

    Topics: Double-Blind Method; Humans; Male; Pelvic Pain; Phosphodiesterase 5 Inhibitors; Prostatitis; Tadalafil

2022
Editorial Comment from Dr Amano to Tadalafil is sufficiently effective for severe chronic prostatitis/chronic pelvic pain syndrome in patients with benign prostatic hyperplasia.
    International journal of urology : official journal of the Japanese Urological Association, 2020, Volume: 27, Issue:1

    Topics: Humans; Male; Pelvic Pain; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Prostatitis; Tadalafil

2020
Editorial Comment from Dr Tanaka to Tadalafil is sufficiently effective for severe chronic prostatitis/chronic pelvic pain syndrome in patients with benign prostatic hyperplasia.
    International journal of urology : official journal of the Japanese Urological Association, 2020, Volume: 27, Issue:1

    Topics: Humans; Male; Pelvic Pain; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Prostatitis; Tadalafil

2020
[Tadalafil Ameliorates Symptoms of Patients with Benign Prostatic Hyperplasia Complicated by Chronic Pelvic Pain Syndrome].
    Hinyokika kiyo. Acta urologica Japonica, 2017, Volume: 63, Issue:3

    Topics: Humans; Male; Middle Aged; Pelvic Pain; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Tadalafil; Treatment Outcome

2017
Effect of tadalafil on chronic pelvic pain and prostatic inflammation in a rat model of experimental autoimmune prostatitis.
    The Prostate, 2018, Volume: 78, Issue:10

    Topics: Animals; Autoimmune Diseases; Chronic Pain; Disease Models, Animal; Humans; Male; Pelvic Pain; Prostate; Prostatitis; Rats; Rats, Wistar; Tadalafil; Urological Agents

2018
Chronic pelvic pain and prostate inflammation in rat experimental autoimmune prostatitis: Effect of a single treatment with phosphodiesterase 5 inhibitors on chronic pelvic pain.
    The Prostate, 2018, Volume: 78, Issue:15

    Topics: Analgesics; Animals; Autoimmune Diseases; Celecoxib; Chemokines; Chronic Pain; Cytokines; Disease Models, Animal; Immunoglobulin G; Male; Pelvic Pain; Phosphodiesterase 5 Inhibitors; Pregabalin; Prostatitis; Rats; Rats, Wistar; RNA, Messenger; Tadalafil

2018
Voiding behavior and chronic pelvic pain in two types of rat nonbacterial prostatitis models: Attenuation of chronic pelvic pain by repeated administration of tadalafil.
    The Prostate, 2019, Volume: 79, Issue:5

    Topics: Animals; Autoimmune Diseases; Chronic Pain; Disease Models, Animal; Male; Orchiectomy; Pelvic Pain; Phosphodiesterase 5 Inhibitors; Prostatitis; Rats; Rats, Wistar; Tadalafil; Urination

2019
Does this case hold the answer to one of the worse types of pain in medicine--that of loin pain haematuria syndrome (LPHS).
    BMJ case reports, 2015, Apr-26, Volume: 2015

    Topics: Adult; Analgesics, Opioid; Drug Administration Schedule; Female; Hematuria; Humans; Pain, Intractable; Pelvic Pain; Phosphodiesterase 5 Inhibitors; Ramipril; Recurrence; Syndrome; Tadalafil; Treatment Outcome; Ureter

2015